Job Summary

• This role provides scientific and operational leadership across oncology programs with a focus on radiopharmaceutical therapeutics at RayzeBio, a subsidiary of Bristol Myers Squibb.
• The successful candidate will lead the in-vivo pharmacology strategy, ensuring high-quality studies inform program strategy from discovery through IND-enabling development while maintaining accountability for animal welfare.
• Compensation ranges from $190,539 to $230,888 annually with comprehensive benefits including health coverage, 401(k), and flexible time off options.

Matching Summary

Salary

Base: $190,539 - $230,888; Bonus/Equity: Incentive cash and stock opportunities available; Benefits: Medical, dental, vision, 401(k), paid time off, and global shutdown

Skills & Requirements

Key Requirements

• Ph.D. in Pharmacology, Cancer Biology, or Toxicology
• 8+ years relevant industry experience
• Track record advancing preclinical programs toward IND
• Working knowledge of IACUC processes and regulations

Work Rights